Vistagen Therap
VTGN----
Vistagen Therap (VTGN)
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Vistagen Therap Analyst Rating
View MoreForecast & Rating
Jun 30, 2026Price forecast
$1.00341.70%
Forecast & RatingHold
4analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Jul 2 at 09:15 AM
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
- Tip Ranks · Jul 1 at 02:55 AM
VistaGen Therapeutics (VTGN) Receives a Rating Update from a Top Analyst
- benzinga_article · Jun 30 at 12:35 PM
Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss
- benzinga_article · Jun 30 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · Jun 30 at 11:08 AM
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June
- Quartr · Jun 30 at 07:18 AM
VTGN: Fasedienol missed primary endpoints in Phase 3, but showed promise in severe social anxiety subgroup
